XOMA Royalty (XOMA) EBT (2011 - 2026)
XOMA Royalty (XOMA) reported EBT of $4.5 million for Q1 2026, up 88.68% on a YoY basis from $2.4 million in Q1 2025, and down 51.41% sequentially from $9.2 million in Q4 2025.
XOMA Royalty (XOMA) EBT (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of EBT data on file, last reported at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 88.68% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.9 million (up 109.54% YoY), and the FY2025 full-year result was $31.8 million, up 263.9% from the prior year.
- EBT retreated to $4.5 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, EBT ranged from a high of $9.2 million in Q4 2025 to a low of -$27.1 million in Q2 2024.
- A 5-year average of -$10.3 million and a median of -$11.1 million in 2023 frame the typical range for EBT.
- Across the five-year window, EBT tumbled 830.49% in 2022 and jumped 196.16% in 2025, its largest moves.
- Tracing XOMA's EBT over 5 years: stood at -$6.3 million in 2022, then tumbled by 225.0% to -$20.3 million in 2023, then jumped by 53.03% to -$9.6 million in 2024, then surged by 196.16% to $9.2 million in 2025, then plunged by 51.41% to $4.5 million in 2026.
- Business Quant data shows XOMA's EBT at $4.5 million in Q1 2026, $9.2 million in Q4 2025, and -$11.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 4.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.47 Mn |
| Dec 31, 2025 | 9.19 Mn |
| Jun 30, 2025 | -11.11 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | -9.56 Mn |
| Sep 30, 2024 | -17.24 Mn |
| Jun 30, 2024 | -27.06 Mn |
| Mar 31, 2024 | -10.78 Mn |
| Dec 31, 2023 | -20.35 Mn |
| Sep 30, 2023 | -12.59 Mn |
| Jun 30, 2023 | -17.39 Mn |
| Mar 31, 2023 | -11.07 Mn |
| Dec 31, 2022 | -6.26 Mn |
| Sep 30, 2022 | -14.66 Mn |
| Jun 30, 2022 | -20.82 Mn |
| Mar 31, 2022 | -2.12 Mn |
| Dec 31, 2021 | 29.95 Mn |
| Sep 30, 2021 | -4.44 Mn |
| Jun 30, 2021 | -2.24 Mn |
| Mar 31, 2021 | -7.37 Mn |